Karen Fallen is the Vice President, Business Unit Head, Clinical Development and Manufacturing for Lonza Pharma & Biotech. This business unit enables customers to successfully develop and supply biotherapeutics for patients by employing innovation in custom development and manufacturing across multiple technologies. Karen joined Lonza in 1989 working in a number of roles of increasing responsibility within the Quality and Sales organizations. Karen also headed the Licensing department where she was responsible for commercialization of Lonza’s GS System® and XS® Expression Technologies. Karen has a Bsc in Biotechnology / Applied Biology and is based in the UK.